Precigen
PGEN
#5013
Rank
C$2.71 B
Marketcap
C$7.62
Share price
-2.53%
Change (1 day)
251.78%
Change (1 year)

Earnings for Precigen (PGEN)

Earnings in 2026 (TTM): -C$0.29 Billion

According to Precigen's latest financial reports the company's current earnings are C$31.59 Million. In 2025 the company made an earning of -C$0.36 Billion a decrease over its 2024 earnings that were of -C$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Precigen from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.29 Billion-19.88%
2025 -C$0.36 Billion95.77%
2024 -C$0.19 Billion32.86%
2023 -C$0.14 Billion20.5%
2022 -C$0.12 Billion-23.33%
2021 -C$0.15 Billion60.11%
2020 -C$91.88 Million-65.1%
2019 -C$0.27 Billion-65.19%
2018 -C$0.76 Billion313.44%
2017 -C$0.19 Billion-33.2%
2016 -C$0.28 Billion123.22%
2015 -C$0.13 Billion1.47%
2014 -C$0.13 Billion109.54%
2013 -C$57.7 Million-50.04%
2012 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-C$3.51 Million-98.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-C$0.11 Billion-64.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-C$90.91 Million-68.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-C$0.21 Billion-27.22% Jersey